Melvin L. Watt bought Incyte Corporation (NASDAQ: INCY)
Melvin L. Watt (D-NC), a U.S. Representative, has disclosed 1 trade in Incyte Corporation (INCY) since 2013, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Melvin L. Watt bought $1,000 - $15,000 of Incyte Corporation (NASDAQ: INCY) on November 4, 2013. Since that trade, INCY is up +183.04% against the S&P 500 up +425.90%, an outperformance of -242.87%.
Data updated
Melvin L. Watt's INCY trades vs the price
INCY is up +183.04% since Melvin L. Watt bought on November 4, 2013, versus +425.90% for the S&P 500.
Performance since this trade
All Melvin L. Watt INCY trades
Melvin L. Watt & INCY trading FAQ
Is it legal for Melvin L. Watt to trade Incyte Corporation (INCY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Incyte Corporation (INCY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Melvin L. Watt buy INCY?
Melvin L. Watt disclosed a purchase of $1,000 - $15,000 of Incyte Corporation (INCY) on November 4, 2013, according to public STOCK Act filings.
How has INCY performed since Melvin L. Watt's trade?
Since Melvin L. Watt bought INCY on November 4, 2013, the stock is up +183.04%, versus +425.90% for the S&P 500 over the same period, an outperformance of -242.87%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional INCY trades?
BullishWhales tracks every disclosed congressional trade in Incyte Corporation (INCY) on the Incyte Corporation congressional trading page, which aggregates filings across all members of Congress.
Melvin L. Watt's INCY tradesAll congressional filings for Incyte CorporationMelvin L. Watt's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.